Chimeric Antigen Receptor (CAR) is a synthetic receptor that redirects T cells to recognize and eliminate cancer cells by targeting specific antigens present on their surface. This innovative approach has shown significant promise in treating certain hematological malignancies, offering a personalized and potent form of immunotherapy.